Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Alaska Air Group, Inc. ALK: This airline company has seen the Zacks Consensus Estimate for its current year earnings increasing 19% over the last 60 days.
Ashford Hospitality Trust, Inc. AHT: This real estate investment trust firm has seen the Zacks Consensus Estimate for its current year earnings increasing 86.5% over the last 60 days.
NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
Pro-Dex, Inc. PDEX: This medical device contract manufacturer company has seen the Zacks Consensus Estimate for its current year earnings increasing 40.9% over the last 60 days.
eGain Corporation EGAN: This customer service infrastructure software company has seen the Zacks Consensus Estimate for its current year earnings increasing 77.8% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ashford Hospitality Trust Inc (AHT): Free Stock Analysis Report
Alaska Air Group, Inc. (ALK): Free Stock Analysis Report
eGain Corporation (EGAN): Free Stock Analysis Report
Pro-Dex, Inc. (PDEX): Free Stock Analysis Report
NRx Pharmaceuticals, Inc. (NRXP): Free Stock Analysis Report